- Identification of Germline Genetic Variants That Increase Prostate Cancer Risk and Influence Development of Aggressive Disease.
- Saunders EJ, Kote-Jarai Z, Eeles RA.
- Cancers (Basel). 2021 Feb 12;13(4):E760. doi: 10.3390/cancers13040760.
- Review
- Free Full Text
- Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer.
- Su D, Wu B, Shi L.
- Front Pharmacol. 2021 Jan 26;11:610601. doi: 10.3389/fphar.2020.610601.
- PMID: 33574757
- PubMed abstract